UPR sensors, such as ATF4, upregulate the expression of the antiapoptotic genes BCL-2 and FLIP and protect tumour cells against apoptosis in response to drug-induced stress, leading to tumour cell resistance to chemotherapeutic drugs [139]. Here, ATF4 is linked to neoplasm.